Related Experiment Videos

Hyperalimentation-induced cholestasis. Increased incidence and severity in premature infants

Insights

Parenteral nutrition can cause cholestatic jaundice in neonates, especially premature infants. Early detection and monitoring for liver dysfunction are crucial in infants receiving this form of nutritional support.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Clinical Nutrition

Background:

  • Parenteral nutrition (PN) is essential for neonates unable to receive enteral feeding.
  • Liver dysfunction, including cholestatic jaundice, is a known complication of PN in infants.
  • The incidence and risk factors for PN-associated cholestasis in neonates require further elucidation.

Purpose of the Study:

  • To investigate the incidence of liver dysfunction, specifically cholestatic jaundice, in neonates receiving parenteral nutrition.
  • To identify factors associated with the development of cholestasis in this vulnerable population.

Main Methods:

  • A cohort of 267 neonates receiving parenteral nutrition was retrospectively monitored.
  • Data collected included clinical signs of liver dysfunction, degree of prematurity, duration of PN, and protein infusate levels.
  • Incidence of cholestatic jaundice and associated factors were analyzed.

Main Results:

  • Cholestatic jaundice occurred in a significant proportion of neonates, with higher incidence in more premature infants.
  • Severity of jaundice showed an inverse correlation with the degree of prematurity.
  • Infants with cholestasis required longer durations of PN and had a higher incidence of sepsis.

Conclusions:

  • Neonates receiving parenteral nutrition are at risk for developing cholestatic jaundice, particularly those who are highly premature.
  • Prolonged PN and sepsis are associated with cholestasis.
  • Close monitoring for liver dysfunction in neonates on PN is strongly recommended.

Related Concept Videos